301 companies
David J Mclachlan
DNLI
Denali Therapeutics Inc
denali therapeutics inc.
California
NASDAQ
Douglas Richard
DYAI
Dyadic International Inc., DE
dyadic international, inc.
Florida
NASDAQ
EDIT
Editas Medicine Inc
unlocking the promise of genome editing to deliver life-changing medicines.
Massachusetts
NASDAQ
EIGR
Eiger BioPharmaceuticals Inc
eiger inc is a research company located in 500 crescent ct ste 300, dallas, texas, united states.
California
NASDAQ
ELEV
Elevation Oncology Inc
elevation oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it.
Massachusetts
NASDAQ
ELOX
Eloxx Pharmaceuticals, Inc.
eloxx pharmaceuticals, inc.
Massachusetts
OTC
ELUT
Elutia Inc - Ordinary Shares
aziyo was created by highcape partners and tissue banks international with the mission of restoring health and mobility to the greatest number of patients.
Maryland
NASDAQ
ENTX
Entera Bio Ltd
entera bio ltd.
Israel
NASDAQ
ENZN
Enzon Pharmaceuticals, Inc.
enzon pharmaceuticals, inc., together with its subsidiaries, engages in licensing drug products.
New Jersey
NASDAQ
ESLA
Estrella Immunopharma Inc
TradeUP Acquisition Corp.
California
NASDAQ
Eureka Therapeutics, Inc.
California
EVAX
Evaxion Biotech A/S
since 2008, evaxion biotech has been pioneering discovery of antigens and neo-epitopes for vaccines and antibodies using artificial intelligence, with the mission to solve some of the world’s most significant challenges to human health.
Denmark
NASDAQ
EXEL
Exelixis Inc
exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer.
California
NASDAQ
EXAI
Exscientia Plc
at the forefront of small molecule drug discovery we are the first company to automate drug design, surpassing conventional human endeavour.
United Kingdom
NASDAQ
FATE
Fate Therapeutics Inc
fate therapeutics is applying leading expertise in stem cell biology and conventional drug discovery to develop small molecule and biologic drugs that: 1) activate stem cells in the body to stimulate healing and repair or block cancer growth; and 2) create and differentiate "pharmaceutical grade" ips cells to enable their use in drug discovery and development, disease modeling, and eventually personalized cell therapies.
California
NASDAQ
FENC
Fennec Pharmaceuticals Inc
fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states.
North Carolina
NASDAQ
FNCH
Finch Therapeutics Group Inc
finch therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform.
Massachusetts
NASDAQ
FMTX
Forma Therapeutics Holdings Inc
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Massachusetts
NASDAQ